Journal
Cancer Immunology, Immunotherapy
Publication Date
2014
Volume
63
Issue
5
Inclusive Pages
513-528
Document Type
Open Access Publication
DOI
10.1007/s00262-014-1527-x
Rights and Permissions
Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer. Panni RZ, Sanford DE, Belt BA, Mitchem JB, Worley LA, Goetz BD, Mukherjee P, Wang-Gillam A, Link DC, Denardo DG, Goedegebuure SP, Linehan DC. Cancer Immunol Immunother. 2014 May;63(5):513-28. doi: 10.1007/s00262-014-1527-x. Epub 2014 Mar 21. The online version of this article (doi:10.1007/s00262-014-1527-x) contains supplementary material, which is available to authorized users. This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
Recommended Citation
Panni, Roheena Z.; Sanford, Dominic E.; Belt, Brian A.; Mitchem, Jonathan B.; Worley, Lori A.; Goetz, Brian D.; Mukherjee, Pinku; Wang-Gillam, Andrea; Link, Daniel C.; DeNardo, David G.; Goedegebuure, S. Peter; and Linehan, David C., "Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer." Cancer Immunology, Immunotherapy. 63, 5. 513-528. (2014).
https://digitalcommons.wustl.edu/open_access_pubs/2953
Supp1
